Cutting Edge Superconductors

Patented MgB2 products
Overview
Raised: $19,687
Rolling Commitments ($USD)
09/03/2023
$323
2011
Healthcare & Pharmaceuticals
HealthTech
B2B
Medium
High
Summary Profit and Loss Statement
FY 2022 | FY 2021 | |
---|---|---|
Revenue |
$0 |
$0 |
COGS |
$0 |
$0 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$-34,202 |
$-16,548 |
Summary Balance Sheet
FY 2022 | FY 2021 | |
---|---|---|
Cash |
$2,308 |
$7,984 |
Accounts Receivable |
$0 |
$0 |
Total Assets |
$139,581 |
$152,883 |
Short-Term Debt |
$0 |
$0 |
Long-Term Debt |
$228,178 |
$207,278 |
Total Liabilities |
$228,178 |
$207,278 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual